Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

December 2017 Issue of The Ophthalmologist

Welcome to the December issue of The Ophthalmologist! Upfront’s topics include the brolucizumab HAWK and HARRIER trial results, and a potential new therapeutic for uveal melanoma. In My View sees Richard Lindstrom focus on driving innovation in the ophthalmic space, and Jesse Berry shares how they’re tackling the challenge of improving retinoblastoma care. In our Feature, The Innovators 2017, some of the leaders in the field showcase their latest and greatest technologies. In Practice sees Elizabeth Yeu discuss how ophthalmologists can combat the modern dry eye epidemic. In NextGen, Michael O’Rourke addresses how sustained drug delivery devices can make it to market, and Alex Huang shares the latest updates on his aqueous angiography work. In Profession, Pablo Artal recommends an optics refresh. Finally, we Sit Down With Chelvin Sng, Consultant Ophthalmologist at National University Hospital, Singapore.

Register to download

Register here to download any issue of The Ophthalmologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Other

Heidelberg Man

| Mark Hillen

Another lament to the loss of a leading figure in ophthalmology…

Subspecialties Retina

A New Dry AMD Target?

| Ruth Steer

A US research team have identified a novel enzyme that appears to play a role in disease progression.

Subspecialties Retina

How Low Can You Go?

| Ruth Steer

Optimizing ROP treatment by scaling back the dose.

Subspecialties Retina

Red Light Means Go?

| Ruth Steer

A recent trial shows promise for a new ocular melanoma therapeutic.

Subspecialties Retina

Quite a Stretch

| Mark Hillen

Can brolucizumab extend the AMD anti-VEGF treatment interval?

Subspecialties Basic & Translational Research

Image of the Month

| Ruth Steer

A beautiful image of an embryonic eye.

Business & Profession Other

In the Midst of an Epidemic

| Ruth Steer

A survey of ophthalmology residents digs into the details of burnout.

Business & Profession Business and Innovation

Get Involved

| Richard Lindstrom

My words of wisdom on working with industry to drive ophthalmic innovation.

Subspecialties Retina

A Whole New World

| Jesse Berry

It shouldn't be about epi-on or epi-off CXL… The focus should be on what's best for patients.

Subspecialties Retina

Jury’s Out

| David A. Eichenbaum

Placing the HAWK/HARRIER data in the wider context of nAMD anti-VEGF trial data.

Business & Profession Other

Innovators 2017

Some of the leading innovators showcase their latest offerings…

Subspecialties Cornea / Ocular Surface

Treating OSD Then and Now

| Elizabeth Yeu

Combating the modern dry eye epidemic.

Subspecialties Business and Innovation

Sustaining Innovation

| Michael O’Rourke

Sustained-release drug delivery technologies over time, and how future innovators should proceed…

Subspecialties Glaucoma

Segmented, Pulsatile and Dynamic

| Alex Huang

Aqueous angiography in living patients…

Business & Profession Other

Recommended Reading for an Optics Refresh

| Pablo Artal

It’s difficult to remember all aspects of your training – especially optics principles…

Subspecialties Cornea / Ocular Surface

Don’t Rub Your Eyes!

| Renato Ambrósio Jr.

It’s a simple message, but it will save sight. All ophthalmologists should help spread the word.

Business & Profession Glaucoma

Driven by Patient Need

| Chelvin Sng

Chelvin Sng, Consultant Ophthalmologist, National University Hospital, Singapore

Subspecialties Refractive

Less Energy, More Impact: How the FEMTO LDV Z8 is Reforming Laser Surgery

How the FEMTO LDV Z8 is reforming laser surgery.

Subspecialties Cataract

Clareon IOL: A New Monofocal Platform

| Sponsored by Alcon

Highlights from Alcon's Satellite Symposium, held on October 9, 2017, at the XXXV Congress of the ESCRS, Lisbon, Portugal.

Other issues of 2017